Clovis Oncology (NASDAQ:CLVS)

CAPS Rating: 3 out of 5

Results 1 - 9 of 9

Recs

0
Member Avatar LMNOPQRStallion (54.89) Submitted: 9/16/2015 12:17:14 AM : Outperform Start Price: $92.75 CLVS Score: -67.27

CLVS is officially in beast mode! Rociletinib positioned well for FDA-approval/robust launch, and rucaparib not far behind looking like best-in-class PARP inhibitor.

As of 15 Sep 2015 market close, $4.0 bin cap still significantly undervalued short-term. Call $5.5 Bln cap by EOY 2015.

$10-15 Bln cap can easily be rationalized as buyout target in near future, anything less would be a steal... if no BO cap grows much higher than this range long-term.

Recs

0
Member Avatar TMFTypeoh (74.44) Submitted: 9/9/2015 12:38:41 PM : Outperform Start Price: $115.45 CLVS Score: -78.82

Winners keep on winning. I'm bullish even after today's monster move.

Recs

0
Member Avatar 1russianguy (< 20) Submitted: 8/20/2015 3:29:53 PM : Outperform Start Price: $71.78 CLVS Score: -65.49

Playing for a bounce from a correction.

Recs

0
Member Avatar navychop2 (29.85) Submitted: 6/11/2014 8:45:02 PM : Underperform Start Price: $43.34 CLVS Score: +50.71

Negative side affects to it's primary experimental cancer drug, burning through cash, can't find a buyer

Recs

1
Member Avatar Jordrok (99.07) Submitted: 9/30/2013 9:18:29 PM : Underperform Start Price: $60.30 CLVS Score: +78.83

No revenue yet...

Recs

0
Member Avatar getrichdietrying (82.31) Submitted: 9/25/2013 1:59:53 PM : Underperform Start Price: $63.92 CLVS Score: +79.92

Buyers are not interested at unjustified market cap valuation. sell and take the profits a great short sell now.

Recs

0
Member Avatar TMFBiologyFool (97.64) Submitted: 9/18/2013 7:00:29 PM : Underperform Start Price: $74.20 CLVS Score: +81.54

Pipeline doesn't justify $2.2 billion valuation.

Recs

0
Member Avatar HoldThatWinner (32.09) Submitted: 6/5/2013 12:12:51 PM : Outperform Start Price: $65.32 CLVS Score: -85.56

$100 Target

Recs

0
Member Avatar IBDContrarian (54.39) Submitted: 4/6/2013 1:49:18 PM : Underperform Start Price: $29.05 CLVS Score: +52.65

IBD EPS, RS, SPROE, Acc ratings plus P/E and div yield
MEDICAL 5 95 -B+ NO EARN

Results 1 - 9 of 9

Featured Broker Partners